An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation in PSMA Positive OMPC.
Clinical trial NCT05939414 · RECRUITING
Trial details
- NCT number
- NCT05939414
- Sponsor
- Novartis Pharmaceuticals
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-03-12
- Primary completion
- 2028-04-25
- Enrollment
- 450
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.